SCIELE PHARMA, INC.
SCIELE PHARMA, INC. (SCRX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 100 transactions totaling $60.9M, demonstrating a bearish sentiment with -$60.7M in net insider flow. The most recent transaction on Aug 15, 2008 involved a sale of 100,000 shares valued at $2.1M.
SCRX Insider Activity Summary
Who Is Buying SCRX Stock?
No significant insider buying has been recorded for SCRX in the recent period.
Who Is Selling SCRX Stock?
No significant insider selling has been recorded for SCRX in the recent period.
Is SCIELE PHARMA, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SCRX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$60.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SCRX Frequently Asked Questions
Understanding SCRX Insider Activity
Insider trading at SCIELE PHARMA, INC. (SCRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading SCRX stock, having executed 100 transactions in the past 90 days. The most active insider is John N. Kapoor (Executive), who has made 3 transactions totaling $41.6M.
Related Tools
Track SCIELE PHARMA, INC. Insider Activity
Get notified when executives and directors at SCRX file new Form 4 transactions